Skip to main content
Fig. 3 | Food Production, Processing and Nutrition

Fig. 3

From: Muscadine or amla extracts standardized to ellagic acid content ameliorate glucolipotoxicity associated β-cell dysfunction via inhibition of IL-1β and improved insulin secretion

Fig. 3

a Effect of ellagic acid (EA), muscadine (MS), amla (AM), or urolithin A (UR) at 0.01-10 μM concentrations on 33.3 mM glucose (Glu)-induced IL-1β levels in NIT-1 cells. b. Effect of ellagic acid (EA), muscadine (MS), amla (AM), or urolithin A (UR) at 0.01-10 μM on 250 μM palmitic acid (PA)-induced IL-1β levels in NIT-1 cells. c Effect of ellagic acid (EA), muscadine (MS), amla (AM), or urolithin A (UR) at 0.01-10 μM concentrations on 33.3 mM glucose (Glu) + 250 μM palmitic acid (PA)-induced IL-1β levels in NIT-1 cells. The values are expressed as percentage of untreated control. Results are mean ± S. D, (n = 2). Letters with different superscripts are significantly different (P < 0.05) among groups

Back to article page